The rising interest in GLP-1 agonists for diabetes has led to a question about delivery routes : skin-applied devices versus pills . Usually , GLP-1 treatments were solely available in oral form, but the https://gretayfcf045621.livebloggs.com/47724398/glp-1-skin-applications-vs-oral-medications-which-right-for-the-patient